Quality Control Mechanisms in Protein Synthesis
蛋白质合成中的质量控制机制
基本信息
- 批准号:10707986
- 负责人:
- 金额:$ 39.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-21 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:Adaptor Signaling ProteinAntibiotic TherapyAntibioticsBacteriaBinding SitesBiochemicalBiogenesisC-terminalCrowdingCytoplasmDataDefectDevelopmentEnzymesEukaryotaExoribonucleasesFamilyFutureGeneticGoalsKnowledgeLightLinkLocationMeasuresMediatingMessenger RNAModelingModificationMolecularMultiple Bacterial Drug ResistanceParticipantPathogenesisPathway interactionsPeptide HydrolasesPlayPositioning AttributeProcessProtein BiosynthesisProteinsProteolysisQuality ControlRNARecyclingRegulatory PathwayResearch Project GrantsRibonucleasesRibosomal Protein S6RibosomesRoleSiteSpecificitySystemTestingTranscriptTranslatingTranslation ProcessTranslationsVirulencecofactordesignendopeptidase Laenhancing factorfitnessimprovedinsightmRNA Decaymembernovelpathogenic bacteriapolyglutamatepolypeptiderecruitribonuclease RtmRNA
项目摘要
Project Summary
The goal of this research project is to gain deeper mechanistic insights into trans-translation, a conserved bacterial system for
translation quality control, directed proteolysis, and nonstop mRNA decay. The fundamental premise of our proposed studies
is that the SmpB-tmRNA mediated trans-translation process solves all of problems caused by nonstop mRNAs, including
rescue and recycling of unproductively stalled ribosomes, proteolysis of the potentially toxic nascent polypeptides, and
selective decay of the causative defect mRNA. We propose that the tmRNA-rescued ribosome serves as a hub for recruitment
of specialized rescue factors and initiation of interconnected salvage pathways. Therefore, over the next five years we will
address two independent aspects of the trans-translation process: (1) adaptor guided proteolysis of tmRNA tagged proteins
and (2) tmRNA-facilitated nonstop mRNA decay. In Aim I, we will investigate whether the translation machinery serves as a
platform for initiating guided proteolysis by recruiting the AAA+ ClpXP protease system to translating ribosomes. The
primary aim of our studies is to investigate a novel substrate recognition mechanism that enables the ClpXP protease, via its
specific-enhancing factor SspB, to capture marked proteins at their site of biogenesis on the ribosome. A detailed knowledge
of how specific substrate are captured via this novel pathway will shed significant new light on how AAA+ enzymes are
directed to define cellular locations and how proteases contribute to cellular fitness and survival under adverse conditions. In
Aim II, we will investigate the link between the tmRNA-mediated ribosome rescue system and the selective capture and
decay of defective mRNAs by RNase R. We wish to elucidate the mechanism by which RNase R is recruited to the translation
machinery and define its exact binding site and interacting partners on the rescued ribosome. We will explore the possibility
that a unique modification of ribosomal components creates specialized ribosomes that play a key role in recruiting RNase R
to tmRNA-rescued ribosomes. Recent studies have provided compelling evidence to demonstrate that the trans-translation
process and ClpXP and Lon proteases are key participants in various regulatory pathways in several pathogenic bacteria, and
therefore are required for pathogenesis. The genetic, biochemical, and structural studies proposed in this project offer the
unique opportunity to gain significant new insights into the trans-translation process and identify new targets for future
development of new antibiotics.
项目摘要
这个研究项目的目标是获得对翻译的更深层次的机械洞察,翻译是一种保守的细菌系统
翻译质量控制、定向蛋白分解和持续的信使核糖核酸衰变。我们建议的研究的基本前提是
SmpB-tmRNA介导的翻译过程解决了由不间断mRNAs引起的所有问题,包括
挽救和回收停滞不前的核糖体,对潜在有毒的新生多肽进行蛋白质分解,以及
致病缺陷基因的选择性衰变。我们认为tmna挽救的核糖体作为招募的中心。
建立专门的救援因素,启动相互关联的打捞路径。因此,在未来五年,我们将
阐述翻译过程的两个独立方面:(1)接头引导的tmna标记蛋白的蛋白分解
(2)tmRNA促进的持续mRNA衰变。在Aim I中,我们将调查翻译机制是否起到了
通过招募AAA+ClpXP蛋白酶系统来翻译核糖体来启动引导蛋白降解的平台。这个
我们研究的主要目的是研究一种新的底物识别机制,使ClpXP蛋白酶能够通过其
特异性增强因子SspB,在核糖体上的生物发生部位捕获标记的蛋白质。详细的知识
通过这一新途径捕获特定底物的研究将为AAA+酶是如何
旨在确定细胞的位置以及蛋白酶如何有助于细胞在不利条件下的健康和存活。在……里面
目的研究tmRNAs介导的核糖体拯救系统与选择性捕获和释放的关系。
RNase R对有缺陷的mRNAs的衰变我们希望阐明RNase R被招募到翻译中的机制
并确定其在被拯救的核糖体上的确切结合部位和相互作用伙伴。我们将探索这种可能性
核糖体成分的独特修饰产生了在招募RNaseR中起关键作用的特殊核糖体
TmRNA拯救的核糖体。最近的研究提供了令人信服的证据证明,音译
Process和ClpXP和Lon蛋白水解酶是几种致病菌不同调控途径的关键参与者,以及
因此都是发病所必需的。这个项目中提出的遗传、生化和结构研究提供了
获得对翻译流程的重要新见解并确定未来新目标的独特机会
开发新的抗生素。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
A. WALI KARZAI其他文献
A. WALI KARZAI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('A. WALI KARZAI', 18)}}的其他基金
Quality Control Mechanisms in Protein Synthesis
蛋白质合成中的质量控制机制
- 批准号:
10444816 - 财政年份:2022
- 资助金额:
$ 39.31万 - 项目类别:
The Role the AAA+ Lon Proteases in Bacterial Pathogenesis
AAA Lon 蛋白酶在细菌发病机制中的作用
- 批准号:
9927592 - 财政年份:2017
- 资助金额:
$ 39.31万 - 项目类别:
A Unique Target for Discovery of Novel Anti-infectives
发现新型抗感染药物的独特目标
- 批准号:
6730793 - 财政年份:2003
- 资助金额:
$ 39.31万 - 项目类别:
相似海外基金
SBIR Phase II: Development of a urine dipstick test that can guide immediate and appropriate antibiotic therapy for treatment of complicated urinary tract infections
SBIR II 期:开发尿液试纸测试,可以指导复杂尿路感染的立即和适当的抗生素治疗
- 批准号:
2213034 - 财政年份:2023
- 资助金额:
$ 39.31万 - 项目类别:
Cooperative Agreement
Personalized Antibiotic Therapy in the Emergency Department: PANTHER Trial
急诊科的个性化抗生素治疗:PANTHER 试验
- 批准号:
10645528 - 财政年份:2023
- 资助金额:
$ 39.31万 - 项目类别:
Strategies for improving the efficacy of combinatorial antibiotic therapy in chronic infections
提高慢性感染联合抗生素治疗疗效的策略
- 批准号:
10736285 - 财政年份:2023
- 资助金额:
$ 39.31万 - 项目类别:
A Novel Bone Targeted Antibiotic Therapy for the Treatment of Infected Fractures
一种治疗感染性骨折的新型骨靶向抗生素疗法
- 批准号:
10603486 - 财政年份:2023
- 资助金额:
$ 39.31万 - 项目类别:
Severe Cutaneous Adverse Reactions Following Outpatient Antibiotic Therapy: A Population-based Study
门诊抗生素治疗后的严重皮肤不良反应:一项基于人群的研究
- 批准号:
449379 - 财政年份:2020
- 资助金额:
$ 39.31万 - 项目类别:
Studentship Programs
Sex-Specific Differences in End-of-Life Burdensome Interventions and Antibiotic Therapy in Nursing Home Residents With Advanced Dementia
患有晚期痴呆症的疗养院居民的临终干预和抗生素治疗的性别差异
- 批准号:
422034 - 财政年份:2020
- 资助金额:
$ 39.31万 - 项目类别:
Optimizing outpatient parenteral antibiotic therapy to support hospital-in-the-home program across the unique environmental conditions of Australia
优化门诊肠外抗生素治疗,以支持澳大利亚独特环境条件下的家庭医院计划
- 批准号:
nhmrc : 1197866 - 财政年份:2020
- 资助金额:
$ 39.31万 - 项目类别:
Investigator Grants
Resistance evolution in the presence of combination antibiotic therapy
联合抗生素治疗下耐药性的演变
- 批准号:
2241853 - 财政年份:2019
- 资助金额:
$ 39.31万 - 项目类别:
Studentship
Host-pathogen interactions in antibiotic therapy for listeriosis
李斯特菌病抗生素治疗中宿主与病原体的相互作用
- 批准号:
18K07106 - 财政年份:2018
- 资助金额:
$ 39.31万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Multipurpose targeted nano-antibiotic therapy to fight tough infection in bones
多用途靶向纳米抗生素疗法可对抗骨骼中的严重感染
- 批准号:
9788269 - 财政年份:2018
- 资助金额:
$ 39.31万 - 项目类别:














{{item.name}}会员




